Table 2

Mortality among patients with systemic corticosteroid use, regardless of use of intestinal acting or inhaled corticosteroids compared with non-use

Corticosteroid usePeriodAbsolute risk (95% CI)Rate per 1000 PYRs (95% CI)Crude HR (95% CI)Adjusted HR* (95% CI)
Non-use7 days4.4 (3.8 to 5.1)6.46 (5.47 to 7.44)
30 days8.8 (7.9 to 9.7)3.12 (2.78 to 3.45)
90 days11.9 (10.9 to 12.9)1.46 (1.33 to 1.60)
1 year15.6 (14.4 to 16.8)0.51 (0.47 to 0.55)
Current use7 days14.2 (11.4 to 17.6)21.81 (16.70 to 26.92)3.38 (2.56 to 4.47)2.10 (1.52 to 2.90)
30 days27.9 (24.2 to 32.1)11.53 (9.60 to 13.45)3.56 (2.92 to 4.35)1.96 (1.56 to 2.47)
90 days36.6 (32.5 to 41.0)5.71 (4.87 to 6.54)3.59 (3.02 to 4.27)1.97 (1.62 to 2.41)
1 year47.6 (43.2 to 52.1)2.22 (1.93 to 2.50)3.75 (3.22 to 4.38)2.05 (1.72 to 2.45)
New use7 days15.7 (10.3 to 23.5)24.20 (13.32 to 35.09)3.75 (2.33 to 6.03)2.88 (1.77 to 4.70)
30 days31.4 (23.9 to 40.5)13.46 (9.18 to 17.73)4.09 (2.92 to 5.73)2.72 (1.92 to 3.85)
90 days46.3 (37.9 to 55.6)7.87 (5.81 to 9.93)4.75 (3.60 to 6.28)3.06 (2.29 to 4.09)
1 year52.5 (43.9 to 61.7)2.83 (2.13 to 3.53)4.43 (3.41 to 5.75)2.89 (2.21 to 3.79)
Chronic use7 days13.7 (10.6 to 17.6)21.04 (15.27 to 26.81)3.26 (2.38 to 4.46)1.89 (1.30 to 2.74)
30 days26.8 (22.6 to 31.6)10.93 (8.79 to 13.07)3.40 (2.71 to 4.25)1.68 (1.29 to 2.19)
90 days33.4 (28.8 to 38.4)5.08 (4.18 to 5.97)3.23 (2.65 to 3.94)1.58 (1.25 to 2.00)
1 year45.9 (40.9 to 51.2)2.05 (1.74 to 2.36)3.54 (2.98 to 4.21)1.74 (1.42 to 2.14)
Recent use7 days6.1 (3.6 to 10.0)8.97 (4.27 to 13.67)1.39 (0.81 to 2.40)1.11 (0.63 to 1.95)
30 days13.9 (10.0 to 19.1)5.12 (3.34 to 6.89)1.63 (1.13 to 2.34)1.15 (0.79 to 1.68)
90 days19.2 (14.7 to 24.9)2.53 (1.78 to 3.28)1.68 (1.24 to 2.30)1.17 (0.84 to 1.61)
1 year26.3 (21.0 to 32.6)0.95 (0.71 to 1.20)1.78 (1.36 to 2.33)1.23 (0.93 to 1.63)
  • *HR adjusted for age, sex, use of cardiovascular medication, hypertension, COPD, liver disease or chronic pancreatitis, alcoholism-related diseases other than those affecting the liver or pancreas, inflammatory bowel disease, rheumatoid arthritis, connective tissue disease, malignancies and modified Charlson Comorbidity Index score.

  • COPD, chronic obstructive pulmonary disease; PYR, person year.